Aims To evaluate the outcome after two types of retinal pigment epithelium (RPE) transplantation techniques.
Methods Fourteen consecutive patients with advanced exudative age-related macular degeneration (AMD) were randomly assigned to RPE-choroid sheet transplantation (group 1) or RPE cell-suspension transplantation (group 2). Outcome measures included best corrected distance and near visual acuity (BCVA), complication and recurrence rates, autofluorescence (AF), angiography, and time-domain and spectral-domain optical coherence tomography (TD- and SD-OCT).
Results A gain of three or more lines in BCVA at 24 months was found in two patients in group 1 and in one patient in group 2, whereas a loss of vision of three or more lines occurred in one patient in each group. Revision surgery for proliferative vitreoretinopathy was required in one patient in group 1. Epiretinal membranes developed in two patients in group 1 and in one patient in group 2. No recurrence occurred in this series. AF showed hyperfluorescence coincident with the graft in group 1, and hyper- and hypofluorescence in irregular patterns in group 2. Revascularisation of the graft was present in all patients in group 1, and a normal choroidal vasculature in the area of RPE atrophy in all patients in group 2. OCT showed a decrease in retinal thickness in all patients, with an improved visualisation of inter- and intralaminar structures with SD-OCT.
Conclusion The anatomical and functional outcome after both RPE transplantation techniques was comparable. Intrastructural irregularities of the sheet assessed using SD-OCT might explain the rather limited visual gain in otherwise successful sheet transplants.
Clinical Trial Registration NCT00401713
- Autologous retinal transplantation
- age-related macular degeneration
- retinal pigment epithelium
- treatment surgery
Statistics from Altmetric.com
- Autologous retinal transplantation
- age-related macular degeneration
- retinal pigment epithelium
- treatment surgery
Despite the introduction of anti-vascular endothelial growth factor (VEGF) treatment resulting in significant improvement of vision in patients with neovascular age-related macular-degeneration (AMD), the treatment for advanced AMD, geographic atrophy and/or non-responders is still controversial. Maculoplasty may be an alternative surgical approach in these patients, with the potential of restoring the retinal anatomy and achieving stable long-term results.1
Transplantation of retinal pigment epithelium (RPE) was introduced more than two decades ago, and considerable progress has been made regarding surgical technique and outcome.2–4 In the clinical situation drawbacks as well as successes have been reported.5–9 Today, autologous RPE is used in clinical studies because homologous transplants make long-term combined immunosuppressive therapies necessary, and these are not well tolerated by elderly patients.10 Besides cell condition, basal lamina changes and cell survival, refinement of surgical technique is an important factor for improvement of anatomical and functional outcome. Two different transplantation techniques are currently used in clinical studies: the RPE-suspension technique and the RPE-choroid-sheet technique.11 12 The RPE-cell suspension, providing limited amounts of cells on a partially defective basal lamina can easily be delivered subretinally through small retinotomies, which can be sealed with a gas bubble. The translocation of a full thickness RPE-choroidal sheet, providing a regular cell sheet of polarised RPE on its own basal lamina carries a high risk for intra- and postoperative complications. Thus, a silicone oil tamponade is mandatory, necessitating a second vitreoretinal surgery for silicone oil removal.
This randomised clinical cohort study is the first study evaluating these two autologous RPE-transplantation techniques in advanced neovascular AMD.
Materials and methods
Consecutive patients with foveal choroidal neovascularisation (CNV) related to AMD were included in the study if they fulfilled all the following criteria: (1) age >50 years; (2) progression of the disease combined with progressive visual loss over the past 3 to 6 months; (3) not suitable for laser therapy and/or or photodynamic therapy (PDT) (large lesions, lesions containing >50% pigment epithelium detachment (PED) or haemorrhage); and (4) ‘non-responders’ to the aforementioned therapies and to at least three, monthly performed, intravitreal anti-VEGF treatments. Non-responders were defined as patients presenting at least two of the following criteria: increase of lesion size (fluorescein angiography), increase of retinal thickness (RT), decrease of best corrected visual acuity (BCVA).
Patients were randomly assigned to receive either a full RPE-choroid sheet transplantation and silicone oil tamponade (group 1) or transplantation of an RPE-cell suspension combined with a gas tamponade (group 2). All surgical procedures were performed by one surgeon (SB). The principles of the surgical technique for the RPE-choroid graft were similar to the technique described by van Meurs et al7 13 After 20 gauge pars plana vitrectomy and/or simultaneous cataract surgery, the membrane removal was performed. Then perfluorocarbon (PFC) was injected, and a retinal quadrangle was surrounded with diathermy and/or intensive laser treatment before tissue preparation in the superior mid peripheral region of the retina. For this manoeuvre a switch from the non-contact wide-angle system (B.I.O.M. II; OCULUS, Wetzlar, Germany) to corneal lenses was performed, and a chandelier light was used. The PFC was removed, and a small amount of fluid was injected subretinally to provide delivery of the transplant with minimal trauma. The graft was gently grasped on its choroidal side and cut free. Then the retina on the flap was removed, and the RPE-choroid sheet was translocated subfoveally. After correct graft positioning, PFC was injected again, followed by a silicone–PFC fluid exchange as the last surgical step. Three to 6 months later, silicone oil removal was planned. Our technique for RPE-cell suspension has been described in detail previously.8 14
Patients were examined before surgery and at 1 week, 1 month, and at 3, 9, 12 and 24 months after surgery. Clinical examinations included BCVA (Early Treatment Diabetic Retinopathy Study (ETDRS) charts), Radner reading charts (logarithm of reading acuity determination (logRAD)), biomicroscopy, autofluorescence, fluorescein and indocyanine green angiography (Heidelberg Engineering GmbH, Heidelberg, Germany), and time-domain and spectral-domain optical coherence tomography (TD- and SD-OCT) scans. In addition, all patients underwent microperimetry at the 24 months follow-up using the MP-1 microperimeter (Nidek Technologies, Vigonza, Italy) with a Goldamm III and a 4-2 threshold algorithm. Two ophthalmologists uninvolved in the selection of the patients and surgery performed the examinations.
A masked statistical analysis was performed using SAS Software version 9.1 (SAS Institute Inc., North Carolina, USA) including univariate and stepwise regression analyses to find differences between both treatment groups and to determine the association between main outcome variables (best- corrected distance and near visual acuity (BCVA) and retinal thickness (RT)) at 24 months, baseline demographics and complication rates. Analyses of variance (ANOVA) were used to determine the association between baseline demographics and time course of BCVA and RT. A two-sided p value less than 0.05 was considered statistically significant.
Fourteen patients who underwent surgery between November 2004 and October 2006 were included in this study. The surgery was uneventful in all patients. Simultaneous cataract surgery was performed in 10 patients; the other four patients were pseudophakic before surgery. No significant difference between the treatment groups and baseline demographics was found (p>0.05), shown in table 1.
In group 1, a proliferative vitreoretinopathy (PVR) retinal detachment developed at 6 weeks after surgery in one patient. Revision surgery consisted of silicone oil removal, re-vitrectomy, membrane peeling, laser treatment and silicone oil tamponade because of a residual retinal detachment nasally superior. Due to massive membrane formation, silicone oil removal was not possible in this patient. All other patients underwent silicone oil removal, and in two patients a simultaneous removal of preretinal membranes was performed. In group 2, a preretinal membrane developed in one patient, but it was not surgically removed because of the patient's low vision. No significant difference for complication rates was found between both treatment groups (p=0.56). No recurrence was encountered in this case series.
In group 1, two patients showed a gain of 3 or more lines in distance BCVA at 24 months. Another patient showed a loss of 3 or more lines at 24 months, and four patients showed stable vision within 2 lines. The two patients with significant improvement in distance acuity regained reading ability during follow-up. Two other patients, one presented with a PVR retinal detachment and a significant loss of distance BCVA, lost reading ability during follow-up. Another patient did not recover reading vision after surgery. In group 2, one patient showed a gain of 3 or more lines in distance BCVA at 24 months, and another patient had a loss of 3 or more lines after surgery. The other five patients presented with stable vision within 2 lines. One patient in this group regained reading ability during follow-up, another patient lost reading vision after surgery, and two other patients did not recover any reading ability at 24 months. No significant difference for distance and near BCVA was found between both treatment groups (p>0.75). In addition, baseline demographics were not significantly associated with the visual outcome in both groups (p>0.05). Details on BCVA are presented in table 2, and in figure 1 and 2.
In group 1, autofluorescence showed hyperfluorescent areas of different intensity corresponding to the RPE-choroid sheet in all cases. These findings showed some decrease in size and loss of intensity up to normal fluorescence during follow-up (figure 3c,d). In group 2, autofluorescence showed areas of hypo- and hyperfluorescence in irregular patterns and well demarked areas of RPE atrophy with absent autofluorescence, remaining similar in size and shape during follow-up (figure 4f). Two cases showed small areas of normal autofluorescence within the area of RPE atrophy. In group 1, revascularisation of the graft was visible on fluorescein and indocyanine green angiography in all cases, but did not correspond to AF of the RPE (figure 3e,f,g,h). In group 2, hyperfluorescence (window defect) was present on fluorescein angiography (figure 4g) and a normal choroidal vasculature on indocyanine green angiography (figure 4h) in the area of RPE atrophy in all cases. In addition, visual acuity did not correlate with intensity of AF.
OCT measurements showed a decrease in RT after surgery in all patients in this case series. In group 1, mean RT at baseline was 565 μm and decreased to 415 μm at 24 months. In group 2, mean RT at baseline was 482 μm and decreased to 322 μm at 24 months. With TD-OCT the RPE-choroid sheet appeared well placed and flat in the subretinal area, while with SD-OCT intralaminal and intrastructural abnormalities were visible within the graft. In the area of atrophy surrounding the graft an enhanced permeability into the choroid was present. This increased permeability was absent in the area of the graft. After RPE cell-suspension, localised increased permeability into the tissue in areas of RPE atrophy was more clearly visualised with SD-OCT than TD-OCT. In both groups, SD-OCT showed abnormal overlying retina with a missing clear outer retinal zone. Details are presented in figure 5.
Microperimetry at 24 months demonstrated retinal fixation over the graft in six patients in group 1, and in two patients in group 2. Fixation was graded as relatively unstable in two patients in group 1, and unstable in four patients in group 1 and in two patients in group 2.
This randomised study evaluated the outcomes of two RPE transplantation techniques in patients with advanced neovascular AMD who were unsuitable for or were non-responders to other forms of treatment. Transplantation of RPE-choroid sheet and RPE-cell suspension enabled the maintenance of distance BCVA or in the best cases the restoration of foveal function. However, reading ability was rarely restored or improved.
Baseline demographics were comparable between both groups in our series (p>0.05). Contrary to other reports15 16 the size of the lesion/haemorrhage and the type of the CNV were not significantly related to the visual outcome in both groups in our study (p>0.05).
The postoperative complication rates were comparable between both treatment groups (p=0.56). Higher surgery-related complication rates were reported after RPE-choroid sheet transplantation.7 8 13–15 17–19 No recurrence of CNV was detected angiographically in any of our patients. This is in accordance with two studies on RPE-choroid sheet cases in geographic atrophy and neovascular AMD.17 18 One comparative study on neovascular AMD reported no recurrence in the graft group, but recurrence in the macular translocation group (four out of 12 patients),16 and another study found recurrence of CNV in 11 out of 84 RPE-choroid sheet cases.15
The functional outcome was comparable between both groups in our series and quite similar to the results reported in the literature.15 17–19 Duration of vision loss has been reported to be a significant predictor for the functional outcome after RPE-choroid sheet transplantation and macular translocation.15–17 Half of the patients included in our study were non-responders to previous treatment, and five patients out of these seven non-responders underwent RPE-choroid sheet transplantation. This longstanding vision loss with already impaired function of the photoreceptors and the neurosensory retina may be another reason for the less favourable visual results in group 1. As our study started in 2004, we were not able to include microperimetry, which would have provided additional information on retinal function in our baseline and early postoperative follow-up. However, eight patients had retinal fixation over the graft at 24 months, but fixation was graded relatively unstable in two patients after RPE-choroid sheet transplantation and unstable in six patients after both RPE transplantation techniques. Other studies reported better results on fixation stability after RPE-choroid sheet transplantation.15 19
Transplantation of RPE-choroid sheet provides an organised cell layer over its own basal lamina, whereas transplantation of RPE-cell suspension has the disadvantage that a limited amount of cells is distributed over a damaged basal lamina with an uncertain fate.20 21 This implies that uneventful transplantation of RPE-choroid sheet, being a better cell source than RPE-cell suspension, may offer a greater chance of regaining normal retinal structures and thus visual function. In addition, our previously published studies on RPE-cell suspension have shown that patients with smaller membranes had a greater chance of regaining vision compared with patients with large pathologies.8 14 Nevertheless, the RPE-choroid sheet group consisting of patients with large pathologies having uneventful transplantation did not show a significantly better outcome. Further evaluation offered two explanations for this limited visual outcome. (1) The RPE-choroid sheets that reached the edge of normal RPE on one side started building RPE bridges from this side. These grafts showed better maintenance in colour and autofluorescence over time. Although two patients presented with regain in vision after surgery, only one of these patients showed a continuous visual recovery over more than 18 months. Five of our RPE-choroid sheet patients presented with grafts not close enough to the normal RPE to create these bridges. In addition, they showed a decrease of the size of the graft, which were surrounded by fibrotic tissue. (2) The RPE-choroid sheets looked regular and well organised on TD-OCT. However, on SD-OCT irregularities in the cell layers within the graft were visualised. These irregularities suspicious of scar formation or increased gliosis may also explain the inadequate visual recovery. In addition, we found an absent clear outer nuclear and photoreceptor layer as previously described by MacLaren et al, which they interpreted as photoreceptor loss over the graft.22
Our study has some limitations. Although there has been no previous report evaluating the outcome after transplantation of RPE-choroid sheet and RPE-cell suspension, the sample size in the present study is relatively small. There may be limited power to detect outcome differences and this may lead to insufficiency of statistical analysis. The 24 months of follow-up seems to be appropriate for evaluating these different transplantation techniques, although anatomical as well as visual outcomes may still change even 3 to 6 years after surgery.22
In conclusion, transplantation of RPE offers an alternative approach in advanced AMD, and is also suitable for geographic AMD and other degenerative retinal diseases. However, the functional results with RPE transplantation techniques do not approach the levels of outcome seen with anti-VEGF treatment. Although complication rates after transplantation of RPE seem to be greater, long-term effects of repeated intravitreal application are still unknown.23 24 Refinement of surgical technique to allow for an adequate graft size, improvement of the quality of RPE and Bruch's membrane (rejuvenation, gene therapy, prosthetic Bruch's membrane, stem cells) and combination therapies might be future options to improve outcome after transplantation of RPE. Refined indications for treatment (eg, patients with fresh RPE rips involving the fovea or ‘non-responders’ at an earlier time) should be evaluated in multicentre trials.
Competing interests None declared.
Patient consent Obtained.
Ethics approval This study was conducted with the approval of the Ethics Committee of the City of Vienna and complied with the Declaration of Helsinki.
Provenance and peer review Not commissioned; externally peer reviewed.